Pharma Journalist - Page 672 of 831 -

Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ, to the U.S. FDA

Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711

Roche enters into a definitive agreement to acquire Poseida Therapeutics, including cell therapy candidates and related platform technologies

MiNA Therapeutics declares publication of Pre-Clinical data endorsing Therapeutic Potential of MTL-CEBPA

Pfizer declares optimistic result of FDA Advisory Committee Meeting on XELJANZ for UC

Canon Medical Systems initiates New Version of Aplio i900 Premium Cardiovascular Ultrasound

RMAT Designation granted by FDA to AmnioFix Injectable for treatment of Osteoarthritis

CTI BioPharma declares publication of Pacritinib Phase 3 PERSIST-2 Clinical Trial in JAMA Oncology

FDA sanctions pivotal Clinical Trial for Technology to treat Overactive Bladder

Amgen declared that data from two new studies suggest barriers to access for PCSK9 inhibitors

SMi’s Pharma Microbiology West Coast 2018 chair and speakers announced

Hear From AstraZeneca at SMi’s HPAPI 2018

Regeneron and Sanofi declare plans to make Praluent more accessible for patients at high risk